Synthesis and cytotoxic activities of β-carboline amino acid ester conjugates

被引:112
作者
Zhao, Ming
Bi, Lanrong
Wang, Wei
Wang, Chao
Baudy-Floc'h, Michele
Ju, Jingfang
Peng, Shiqi
机构
[1] Univ S Alabama, Mitchell Canc Inst, Mobile, AL 36688 USA
[2] Capital Univ Med Sci, Coll Pharmaceut Sci, Beijing 100054, Peoples R China
[3] Peking Univ, Coll Pharmaceut Sci, Beijing 100083, Peoples R China
[4] Univ Rennes 1, CNRS, UMR 6226, Grp Ciblage & Autoassemblages Fonct, F-35042 Rennes, France
关键词
beta-carboline; cytotoxicity; anti-cancer;
D O I
10.1016/j.bmc.2006.06.021
中图分类号
Q5 [生物化学]; Q7 [分子生物学];
学科分类号
071010 ; 081704 ;
摘要
beta-Carboline represents a class of compounds with potent anti-tumor activity by intercalating with DNA. To further enhance the cytotoxic potency and bioavailability of beta-carboline, a series of novel beta-carboline amino acid ester conjugates were designed and synthesized, and the cytotoxic activities of these compounds were tested using a panel of human tumor cell lines. In addition, the membrane permeability of these compounds was evaluated in vitro using a Caco-2 cell monolayer model. The P-carboline amino acid ester conjugates demonstrated improved cytotoxic activity compared to the parental beta-carbolines. In particular, the Lys/Arg conjugates were the most potent analogs with an IC50 value of 4 and 1 mu M against human cervical carcinoma cells. The low interaction energy of Arg conjugate based on molecular modeling may contribute to its enhanced cytotoxicity. Taken together, this study provided new insights into structure-activity relationships in the beta-carboline amino acid ester conjugates and identified the beta-carboline Lys/Arg conjugates as promising lead compounds for further in vivo biological and molecular evaluation. (c) 2006 Elsevier Ltd. All rights reserved.
引用
收藏
页码:6998 / 7010
页数:13
相关论文
共 70 条
[51]   The search of DNA-intercalators as antitumoral drugs:: what it worked and what did not work [J].
Martínez, R ;
Chacón-García, L .
CURRENT MEDICINAL CHEMISTRY, 2005, 12 (02) :127-151
[52]   Novel approaches towards development of non-classical platinum-based antineoplastic agents: Design of platinum complexes characterized by an alternative DNA-binding pattern and/or tumor-targeted cytotoxicity [J].
Momekov, G ;
Bakalova, A ;
Karaivanova, M .
CURRENT MEDICINAL CHEMISTRY, 2005, 12 (19) :2177-2191
[54]   Synthesis of NK109, an anticancer benzo[c]phenanthridine alkaloid [J].
Nakanishi, T ;
Suzuki, M ;
Mashiba, A ;
Ishikawa, K ;
Yokotsuka, T .
JOURNAL OF ORGANIC CHEMISTRY, 1998, 63 (13) :4235-4239
[55]  
NEIDLE S, 1983, MOL ASPECTS ANTICANC
[56]   TRANSCRIPTION FACTORS - STRUCTURAL FAMILIES AND PRINCIPLES OF DNA RECOGNITION [J].
PABO, CO ;
SAUER, RT .
ANNUAL REVIEW OF BIOCHEMISTRY, 1992, 61 :1053-1095
[57]   SYNTHESIS AND STRUCTURE-ACTIVITY RELATIONSHIP OF METHYL-SUBSTITUTED INDOLE[2,3-B]QUINOLINES - NOVEL CYTOTOXIC, DNA TOPOISOMERASE-II INHIBITORS [J].
PECZYNSKACZOCH, W ;
POGNAN, F ;
KACZMAREK, L ;
BORATYNSKI, J .
JOURNAL OF MEDICINAL CHEMISTRY, 1994, 37 (21) :3503-3510
[58]   A CARBOLINE DERIVATIVE AS A NOVEL MAMMALIAN DNA TOPOISOMERASE-II TARGETING AGENT [J].
POGNAN, F ;
SAUCIER, JM ;
PAOLETTI, C ;
KACZMAREK, L ;
NANTKANAMIRSKI, P ;
MORDARSKI, M ;
PECZYNSKACZOCH, W .
BIOCHEMICAL PHARMACOLOGY, 1992, 44 (11) :2149-2155
[59]  
Propst C.L., 1992, Nucleic acid targeted drug design
[60]  
RADIC MZ, 1994, ANNU REV IMMUNOL, V12, P487, DOI 10.1146/annurev.iy.12.040194.002415